
zzso is a new zzso recently developed by the French company zzso It is chemically characterized by the graft of an zzso acid on the zzso zzso which makes it highly zzso The zzso studies revealed a lower zzso and zzso when compared to zzso The zzso studies showed a high body clearance and a short zzso The phase I study enabled us to determine the definitive treatment schedule: 100 zzso during zzso consecutive weeks followed by 5 zzso rest and a maintenance therapy of 100 zzso every 3 weeks for stabilized or responding zzso zzso should be given as a zzso intravenous infusion, protected from zzso There was no life-threatening toxicity and positive activity was observed in different tumors and especially zzso This indication was thus chosen for the phase II zzso Among the 153 zzso patients, the response rate reached zzso It depended on the location of the zzso sites, with zzso brain zzso zzso visceral zzso zzso liver zzso and zzso skin and zzso zzso zzso The median duration of response was 22 zzso The median overall survival of responding patients reached 85 weeks, while it dropped to 52 weeks in case of minor response or stabilization and 17 weeks in case of zzso The zzso toxicity was moderate zzso grade III and zzso zzso zzso and zzso zzso and delayed as for other zzso zzso white blood zzso day 44 and zzso day zzso zzso AT 250 zzso 

